Bilaketaren emaitzak - Gyeyoung Choi
- Erakusten 1 - 3 emaitzak -- 3
-
1
Price and Prejudice? The Value of Chimeric Antigen Receptor (CAR) T-Cell Therapy nork Gyeyoung Choi, Gyeongseon Shin, SeungJin Bae
Argitaratua 2022Artigo -
2
Efficacy and safety of <scp>PAC</scp> ‐14028 cream – a novel, topical, nonsteroidal, selective <scp>TRPV</scp> 1 antagonist in patients with mild‐to‐moderate atopic dermatitis: a p... nork Y.W. Lee, Chong Hyun Won, Kyoung-Mi Jung, Hyunwoo Nam, Gyeyoung Choi, Y.‐H. Park, Mi‐Young Park, Beom Joon Kim
Argitaratua 2019Artigo -
3
Asivatrep, a TRPV1 antagonist, for the topical treatment of atopic dermatitis: Phase 3, randomized, vehicle-controlled study (CAPTAIN-AD) nork Chun Wook Park, Beom Joon Kim, Yang Won Lee, Chong Hyun Won, Chang Ook Park, Bo Young Chung, Dong Hun Lee, Kyoung-Mi Jung, Hyun-Jin Nam, Gyeyoung Choi, Youngho Park, Kyu Han Kim, Miyoung Park
Argitaratua 2021Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Internal medicine
Medicine
Adverse effect
Anesthesia
Antagonist
Atopic dermatitis
Dermatology
Dermatology Life Quality Index
Disease
Randomized controlled trial
Receptor
TRPV1
Transient receptor potential channel
Visual analogue scale
Chimeric antigen receptor
Clinical endpoint
Cytokine release syndrome
Eczema Area and Severity Index
Immune system
Immunology
Immunotherapy
Intensive care medicine
Lymphoma
Oncology
SCORAD